TLR3 preconditioning induces anti-inflammatory and anti-ictogenic effects in mice mediated by the IRF3/IFN-β axis

C. Kostoula, T. Shaker, M. Cerovic, I. Craparotta, S. Marchini, E. Butti, R. Pascente, V. Iori, C. Garlanda, E. Aronica, G. Martino, T. Ravizza, L. Carmant, A. Vezzani

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Activation of Toll-like receptor 3 (TLR3) was previously shown to contribute to the generation of epileptic seizures in rodents by evoking a proinflammatory response in the forebrain. This suggests that TLR3 blockade may provide therapeutic effects in epilepsy. We report that brain activation of TLR3 using the synthetic receptor ligand Poly I:C may also result in remarkable dose- and time-dependent inhibitory effects on acute seizures in mice without inducing inflammation. These inhibitory effects are associated with reduced neuronal excitability in the hippocampus as shown by a decrease in the population spike amplitude of CA1 pyramidal neurons following Schaffer collaterals stimulation. TLR3 activation which results in seizure inhibition does not evoke NF-kB-dependent inflammatory molecules or morphological activation of glia, however, it induces the alternative interferon (IFN) regulatory factor (IRF)-3/IFN-β signaling pathway. IFN-β reproduced the inhibitory effects of Poly I:C on neuronal excitability in hippocampal slices. Seizure inhibition attained with activation the TLR3-IRF3/IFN-β axis should be carefully considered when TLR3 are targeted for therapeutic purposes.
Original languageEnglish
Pages (from-to)598-607
JournalBrain, Behavior, and Immunity
Volume81
DOIs
Publication statusPublished - 1 Oct 2019
Externally publishedYes

Cite this